Fact Sheet: The Biden-Harris administration announced a strategy to strengthen health security and prepare for biothreats | Techno Glob

Today, President Joe Biden will sign and launch National Security Memorandum-15 (NSM-15). National Biosecurity Policy and Implementation Plan to Combat Biological Threats, Enhance Pandemic Preparedness and Achieve Global Health Security (Strategy).

As the President has said, there are no walls high enough or oceans wide enough to keep out biohazards and protect our communities. The strategy reflects the Biden-Harris administration’s comprehensive plan to protect our nation from future pandemics and biological threats. In our international partnership, we have a set of bold goals to transform the nation’s biosecurity and health security by launching a whole-of-government effort across 20 federal agencies to detect, prevent, prepare for, respond to, and recover from biological incidents. , state, local, tribal, regional and private sector partners. NSM-15 supports policy implementation by strengthening coordination of biodefense efforts across the government.

Infectious diseases that cross borders and disrupt societies are a threat to our national security and global stability. Covid-19 is the latest example of how biological threats can devastate communities across the US and around the world, resulting in millions of deaths and trillions of dollars in economic losses globally. In addition to Covid-19, the global community is simultaneously battling outbreaks of monkeypox, polio, Ebola, highly pathogenic avian influenza and other diseases, stretching thin global resources and exposing gaps in our current preparedness. And, the dangers of the weaponization of biological agents are expanding.

The United States must prepare for outbreaks from any source—whether natural, accidental, or deliberate. Urbanization, climate change and habitat encroachment increase the risk of animal outbreaks from reservoirs. Global interconnectedness accelerates the spread of infectious diseases around the world, especially with overwhelmed health systems. Moreover, regulations against the development and use of biological weapons have been challenged by state and non-state actors over the past several decades.

The administration is already implementing key policy actions with existing funds. However, fully achieving these transformative goals will require support from Congress to provide additional resources, including the President’s request for $88 billion over five years for pandemic preparedness and biosecurity. The Administration looks forward to working with Congress to implement this investment strategy to save trillions of dollars and millions of lives.

The policy determines:
Detect epidemics and other biological threats: The strategy aims to develop early warning of infectious disease threats and accelerate the deployment of new technologies that can rapidly detect new pathogens. Real-time information will improve decision-making by planning an all-hazards hospital data collection system, expanding platforms to aggregate and share data for response, and improving data sharing internationally. These efforts are based on the recently launched Center for Forecasting and Outbreak Analytics, which equates to a “National Weather Service” for infectious disease outbreaks, using data, modeling and analytics to enable rapid, effective decision-making to improve outbreak response.

Prevent outbreaks from becoming epidemics and prevent biological events before they occur:

  • Stopping outbreaks at their source by strengthening global health security: The United States will support at least 50 countries to prevent, detect, and respond to infectious disease threats, and encourage other donors and partners to support an additional 50 countries. The United States will also invest in critical multilateral institutions that further strengthen the global health architecture. The administration has already accelerated these efforts by leading the charge to establish a new Financial Intermediary Fund for Pandemic Prevention, Preparedness and Response at the World Bank. With the United States and more than 20 countries initially contributing more than $1.4 billion in seed funding, this new funding will help fill large readiness gaps at national, regional and global levels. The strategy also builds on USAID’s announcement earlier this year of $150 million to the Coalition for Epidemic Preparedness Innovations to accelerate the development of life-saving vaccines and counter biological threats. The United States will continue to support and strengthen the World Health Organization, which plays a critical role in strengthening health systems around the world to better prepare for and respond to health emergencies.
  • Strengthening Laboratory Biosafety and Biosecurity: The United States will work with domestic and international partners to prevent laboratory accidents by strengthening biosafety laboratory capacity, strengthening rules of responsible conduct for biological research, and accelerating biosafety and biosecurity innovation in the United States and abroad. These efforts include galvanizing support for multilateral biosafety and biosecurity commitments and establishing international mechanisms to enhance biosafety and biosecurity globally.
  • Preventing the Use and Development of Bioweapons: The United States will also invest in pathbreaking technologies to detect and characterize the use of biological weapons and work with foreign partners to prevent the use and decisive response if biological weapons are deployed. The United States will work to strengthen international norms against conventional and new biological weapons, including efforts under the Biological Weapons Convention to promote greater transparency among all nation-states.

Prepare for epidemics and other biological events: The policy aims to transform our preparedness to respond to outbreaks American Pandemic Preparedness Plan: Changing our abilities, 2021 was issued by the administration. The United States will work to strengthen and modernize domestic public, veterinary, and plant health capabilities at every level, from rural jurisdictions to large cities, so that outbreaks in humans, animals, and plants can be identified and quickly and equitably controlled. This effort includes recruiting, training, and retaining a strong, flexible, permanent cadre of essential critical health infrastructure workers, outbreak emergency responders, public health laboratory scientists, technicians, data quality managers, and animal disease epidemiologists in all 50 states. The strategy will increase the coordination of evidence-based public health information campaigns among federal, state, and local governments, with the goal of reaching 80% of the American population.

The strategy aims to implement a new ambitious timeline in the development of novel vaccines following the determination of a nationally or internationally significant biological event (including a high-impact outbreak or potential pandemic). These goals reinforce key elements of the 100-day mission, which was welcomed by President Biden and G7 leaders last year, and is catalyzing international cooperation in support of urgent global biodefense goals. Over the next 5-10 years, it aims to:

  • Enable testing within 12 hours, scale up to thousands of diagnostic tests in a week and develop rapid diagnostics in 90 days;
  • develop a vaccine within 100 days; to produce enough vaccine for the population of the United States within 130 days; and work with international partners to develop adequate vaccine supplies for high-risk global populations within 200 days; and,
  • Accelerate therapeutic development and validation to reproduce existing drugs within 90 days or develop new therapies within 180 days.

Respond rapidly to outbreaks when they occur: To effectively leverage these capabilities, the strategy strengthens the United States’ readiness to respond within days to any significant biological event in a coordinated, comprehensive, and just manner. This effort includes preparing to activate an integrated federal research agenda within 14 days of the determination of a domestically or internationally significant biological event, and infrastructure for clinical trials within 14 days of the identification of viable countermeasures to rapidly evaluate vaccines, treatments, and diagnostics. response

Recover from an epidemic or biological event: Finally, the policy ensures that the federal government, in close partnership with state, local, tribal and territorial governments and communities, is prepared to coordinate a long-term, equitable recovery strategy for any significant biological event.

To support the implementation of the strategy, the promulgation of National Security Memorandum-15 (NSM-15) strengthens the coordination of biodefense efforts within the federal government to combat biological threats, enhance pandemic preparedness, and achieve global health security:

  • Centralizing policy coordination in the White House to ensure accountability for policy implementation and to bring together the strengths of all federal agencies in doing so.
  • Directing departments and agencies to prioritize biodefense and strategy implementation in their annual budgets.
  • Directing the Intelligence Community to closely monitor the evolving biothreat threat landscape and provide critical and potentially time-sensitive information needed to address naturally occurring, accidental, and intentional biothreats.
  • Ensuring that the federal government adapts to the ever-evolving threat landscape by using annual biodefense emergency response plans, reviewing ongoing responses, and regularly adjusting federal priorities for lessons learned.

Together, these efforts will help protect Americans from disease outbreaks, epidemics, and the use of biological weapons, and they will enable us to equally strengthen the health of our homeland.


Source link